Shine-On BioMedical Co., Ltd.
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
The company’s pipeline features novel therapeutic candidates, such as precision-engineered exosomes for targeted drug delivery and nanometer-scale trispecific antibodies that engage T cells. These next-generation biologics are designed to improve the spec
Founded Year
2021
Unified Business No.
90841519
Status
Active
Number of Employees
0
Total Paid-in
Capital
498,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
Emerging Stock Exchange(2022)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
The company has developed a series of first-in-human novel drugs that are based on the innovative technology platforms of “targeted exosome for drug delivery” and “trispecific T-cell engager antibody”. The Company has various technical patents for the exo
